The development and progression of adenocarcinoma of the lung.

This chapter has briefly reviewed the development and progression of peripheral-type adenocarcinoma of the lung, focusing particularly on bronchioloalveolar carcinoma consisting of the nonmucus-producing cell type with or without sclerosis. Histoloical examination reveals that scar cancers are rare except in cases of diffuse pulmonary fibrosis and that many nonmucus-producing bronchioloalveolar carcinomas appear to develop from atypical adenomatous hyperplasia, which can be called adenoma or very well-differentiated adenocarcinoma, and to progress stepwise. Stepwise progression in malignancy can be disclosed not only by cytological and histological examination but also by proliferative activity of the tumor, such as mitotic activity, the percentage of DNA-synthesizing cells and the frequency of proliferating cell nuclear antigen-positive cells, the mean nuclear DNA content of tumor cells and occurrence of aneuploid cell lines, and abnormalities of oncogenes (c-Ki-ras, myc family, and c-erbB2), such as point mutation, rearrangement, amplification, and tumor suppressor genes (point mutation and deletion) such as p53.

[1]  Y. Nishiwaki,et al.  Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers , 1980, The American journal of surgical pathology.

[2]  M. Melamed,et al.  Morphogenesis of lung cancer , 1982 .

[3]  Morphometric study of adenocarcinomas and hyperplastic epithelial lesions in the peripheral lung. , 1986, American journal of clinical pathology.

[4]  M Terada,et al.  Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Noguchi,et al.  Loss of genes on the short arm of chromosome 11 in human lung carcinomas. , 1987, Japanese journal of cancer research : Gann.

[6]  N. Müller,et al.  Glandular neoplasia of the lung. A proposed analogy to colonic tumors , 1988, Cancer.

[7]  L. Pitts,et al.  Proliferative potential of brain metastases , 1988, Cancer.

[8]  S. Rodenhuis,et al.  Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. , 1988, Cancer research.

[9]  F. Clayton.  The spectrum and significance of bronchioloalveolar carcinomas. , 1988, Pathology annual.

[10]  S. Morinaga,et al.  A cell kinetic study of pulmonary adenocarcinoma by an immunoperoxidase procedure after bromodeoxyuridine labeling , 1989, Cancer.

[11]  M. Noguchi,et al.  Amplification of protooncogenes in surgical specimens of human lung carcinomas. , 1989, Cancer research.

[12]  H. Asamura,et al.  DNA cytofluorometric and nuclear morphometric analyses of lung adenocarcinoma , 1989, Cancer.

[13]  H. Asamura,et al.  Nuclear DNA content by cytofluorometry of stage I adenocarcinoma of the lung in relation to postoperative recurrence. , 1989, Chest.

[14]  Roberta R. Miller.  Bronchioloalveolar Cell Adenomas , 1990, The American journal of surgical pathology.

[15]  S. Hirohashi,et al.  Heterogeneity of Proliferative Activity in Nodule‐in‐Nodule Lesions of Small Hepatocellular Carcinoma , 1990, Japanese journal of cancer research : Gann.

[16]  W. Bodmer,et al.  p53 mutations in colorectal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Weiner,et al.  p185neu expression in human lung adenocarcinomas predicts shortened survival. , 1990, Cancer research.

[18]  M. Noguchi,et al.  Clinicopathologic and immunohistochemical characteristics of bronchial gland cell type adenocarcinoma of the lung. , 1990, American journal of clinical pathology.

[19]  R. Tsuchiya,et al.  Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[20]  S. Hirohashi,et al.  Association of point mutation in c‐Ki‐ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes , 1990, Cancer.

[21]  K. Gatter,et al.  Monoclonal antibody Ki‐67: its use in histopathology , 1990, Histopathology.

[22]  M. Noguchi,et al.  Clinicopathologic characteristics of adenosquamous carcinoma of the lung , 1991, Cancer.

[23]  Tumor cell heterogeneity and subpopulations with metastatic ability in differentiated adenocarcinoma of the lung. Histologic and cytofluorometric DNA analyses. , 1991, Chest.

[24]  T. Nakajima,et al.  Cytofluorometric analysis of metastases from lung adenocarcinoma with special reference to the difference between hematogenous and lymphatic metastases , 1991, Cancer.

[25]  Clinicopathologic and Immunohistochemical Characteristics of Goblet Cell Type Adenocarcinoma of the Lung , 1991, Acta pathologica japonica.

[26]  H. Kato,et al.  Clinicopathological Significance of Nuclear Accumulation of Tumor Suppressor Gene p53 Product in Primary Lung Cancer , 1992, Japanese journal of cancer research : Gann.

[27]  T. Sekiya,et al.  Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. , 1992, Cancer research.

[28]  S. Hirohashi,et al.  Adenocarcinoma of the Lung with Selective Metastasis to the Lung: Clinical, Histologic and DNA‐Cytofluorometric Analyses , 1992, Japanese journal of cancer research : Gann.

[29]  C. Harris,et al.  Biological consequences of overexpression of a transfected c-erbB-2 gene in immortalized human bronchial epithelial cells. , 1993, Cancer research.

[30]  M. Noguchi,et al.  Adenocarcinoma of the lung: its development and malignant progression , 1993 .

[31]  S. Hirohashi,et al.  Application of the p53 Gene Mutation Pattern for Differential Diagnosis of Primary Versus Metastatic Lung Carcinomas , 1993, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[32]  S. Sternberg,et al.  Diagnostic surgical pathology , 1994 .

[33]  Yoshihiro Matsuno,et al.  Surgically Curable “Early” Adenocarcinoma in the Periphery of the Lung , 1994, The American journal of surgical pathology.